17
Nov 2026
DNA modification linked to milder muscular dystrophy disease outcomes
Two siblings inherited the same rare genetic disease-a type of muscular dystrophy that progressively weakens the muscles of the face, shoulders, and limbs.
17
Nov 2026
Two siblings inherited the same rare genetic disease-a type of muscular dystrophy that progressively weakens the muscles of the face, shoulders, and limbs.
17
Nov 2026
Cleveland Clinic contributed $1.59 billion in community impact across Ohio, Florida and Nevada in 2025.
17
Nov 2026
A new review in Genes & Diseases highlights how the genetic makeup of lung tumors and their surrounding immune environment can help explain why immunotherapy works well for some patients but offers limited benefit to others.
17
Nov 2026
A review in Genes & Diseases highlights how lactate, a molecule long associated with energy metabolism, may influence heart damage and repair after blood flow is restored following a heart attack.
17
Nov 2026
Germany's COVID-19 traffic light is on red (https://corona-ampel.de/), and the number of infections is high. But how well is the population protected against the virus variants currently circulating? The new SARS-CoV-2 variant PJ.2.1 has been spreading since May and has long since reached Europe.
17
Nov 2026
A review published in Genes & Diseases highlights how RNA molecules could help breast cancer cells respond more effectively to radiotherapy.
17
Nov 2026
A review published in Genes & Diseases highlights how strengthening immunity in the nose and airways could improve protection against respiratory infections.
17
Nov 2026
A review in Genes & Diseases explores how a system designed to restore protein balance can influence an inflammatory form of cell death.
17
Nov 2026
City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, and Adagene Inc., a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, today announced the launch of an innovative Phase 1 clinical trial to explore a new combination therapy for patients battling metastatic colorectal cancer, particularly for those whose disease has resisted standard treatments.
17
Nov 2026
Protein patterns in melanoma tumors can predict how patients respond to immunotherapy and can be used to find promising biomarkers and drug targets, according to two new University of Pittsburgh studies.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more